HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota

ABSTRACT Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono mety...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedical chromatography 2012-04, Vol.26 (4), p.524-533
Hauptverfasser: Alava, Pradeep, Tack, Filip, Laing, Gijs Du, de Wiele, Tom Van
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 533
container_issue 4
container_start_page 524
container_title Biomedical chromatography
container_volume 26
creator Alava, Pradeep
Tack, Filip
Laing, Gijs Du
de Wiele, Tom Van
description ABSTRACT Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/bmc.1700
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_bmc_1700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BMC1700</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</originalsourceid><addsrcrecordid>eNp10E9PwjAYx_HGaATRxFdgevQyfNrRf0ddFEhAMWpMjEnTlQ6qbCPrUHn3joDcPPXyye9JvwidE-gSAHqV5rZLBMABahNQKgIJ5BC1gXIVxVKoFjoJ4QMAFKfiGLUoUcCAyTZ6H0xGSTRMJtH4CeeunpdTPHVfblEuc1fUuC5xXha-LitsquAKb3FYOutN7csC27kpZi7gdI3nq9wUeLaqce5tVaa-rM0pOsrMIriz3dtBL3e3z8kgGj30h8n1KLI92oOICEoyQhSVtgdCQaZSbgyTxHJmLaNGCGld81FnZBr3WCo4ZTHlJOMWHJ_GHXS53W0Oh1C5TC8rn5tqrQnoTSDdBNKbQA292NLlKs3ddA__ijQg2oJvv3Drf4f0zTjZDe68D7X72XtTfWouYsH0631fD5iUk7fHsR7Fv7NpfS0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Alava, Pradeep ; Tack, Filip ; Laing, Gijs Du ; de Wiele, Tom Van</creator><creatorcontrib>Alava, Pradeep ; Tack, Filip ; Laing, Gijs Du ; de Wiele, Tom Van</creatorcontrib><description>ABSTRACT Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.1700</identifier><identifier>PMID: 21905058</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>arsenic ; Arsenic - analysis ; Arsenic - metabolism ; Arsenicals - analysis ; Arsenicals - metabolism ; AsIII ; AsV ; Calibration ; Carcinogens - analysis ; Carcinogens - metabolism ; Chromatography, High Pressure Liquid - methods ; colon suspension ; DMAIII ; DMAV ; gastrointestinal ; Gastrointestinal Tract - microbiology ; Humans ; intestine ; Mass Spectrometry - methods ; Metagenome ; Methylation ; MMAIII ; MMAV ; nonequimolar ; Sensitivity and Specificity ; SHIME ; speciation</subject><ispartof>Biomedical chromatography, 2012-04, Vol.26 (4), p.524-533</ispartof><rights>Copyright © 2011 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</citedby><cites>FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbmc.1700$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbmc.1700$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21905058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alava, Pradeep</creatorcontrib><creatorcontrib>Tack, Filip</creatorcontrib><creatorcontrib>Laing, Gijs Du</creatorcontrib><creatorcontrib>de Wiele, Tom Van</creatorcontrib><title>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</title><title>Biomedical chromatography</title><addtitle>Biomed. Chromatogr</addtitle><description>ABSTRACT Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley &amp; Sons, Ltd.</description><subject>arsenic</subject><subject>Arsenic - analysis</subject><subject>Arsenic - metabolism</subject><subject>Arsenicals - analysis</subject><subject>Arsenicals - metabolism</subject><subject>AsIII</subject><subject>AsV</subject><subject>Calibration</subject><subject>Carcinogens - analysis</subject><subject>Carcinogens - metabolism</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>colon suspension</subject><subject>DMAIII</subject><subject>DMAV</subject><subject>gastrointestinal</subject><subject>Gastrointestinal Tract - microbiology</subject><subject>Humans</subject><subject>intestine</subject><subject>Mass Spectrometry - methods</subject><subject>Metagenome</subject><subject>Methylation</subject><subject>MMAIII</subject><subject>MMAV</subject><subject>nonequimolar</subject><subject>Sensitivity and Specificity</subject><subject>SHIME</subject><subject>speciation</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E9PwjAYx_HGaATRxFdgevQyfNrRf0ddFEhAMWpMjEnTlQ6qbCPrUHn3joDcPPXyye9JvwidE-gSAHqV5rZLBMABahNQKgIJ5BC1gXIVxVKoFjoJ4QMAFKfiGLUoUcCAyTZ6H0xGSTRMJtH4CeeunpdTPHVfblEuc1fUuC5xXha-LitsquAKb3FYOutN7csC27kpZi7gdI3nq9wUeLaqce5tVaa-rM0pOsrMIriz3dtBL3e3z8kgGj30h8n1KLI92oOICEoyQhSVtgdCQaZSbgyTxHJmLaNGCGld81FnZBr3WCo4ZTHlJOMWHJ_GHXS53W0Oh1C5TC8rn5tqrQnoTSDdBNKbQA292NLlKs3ddA__ijQg2oJvv3Drf4f0zTjZDe68D7X72XtTfWouYsH0631fD5iUk7fHsR7Fv7NpfS0</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Alava, Pradeep</creator><creator>Tack, Filip</creator><creator>Laing, Gijs Du</creator><creator>de Wiele, Tom Van</creator><general>John Wiley &amp; Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201204</creationdate><title>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</title><author>Alava, Pradeep ; Tack, Filip ; Laing, Gijs Du ; de Wiele, Tom Van</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>arsenic</topic><topic>Arsenic - analysis</topic><topic>Arsenic - metabolism</topic><topic>Arsenicals - analysis</topic><topic>Arsenicals - metabolism</topic><topic>AsIII</topic><topic>AsV</topic><topic>Calibration</topic><topic>Carcinogens - analysis</topic><topic>Carcinogens - metabolism</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>colon suspension</topic><topic>DMAIII</topic><topic>DMAV</topic><topic>gastrointestinal</topic><topic>Gastrointestinal Tract - microbiology</topic><topic>Humans</topic><topic>intestine</topic><topic>Mass Spectrometry - methods</topic><topic>Metagenome</topic><topic>Methylation</topic><topic>MMAIII</topic><topic>MMAV</topic><topic>nonequimolar</topic><topic>Sensitivity and Specificity</topic><topic>SHIME</topic><topic>speciation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alava, Pradeep</creatorcontrib><creatorcontrib>Tack, Filip</creatorcontrib><creatorcontrib>Laing, Gijs Du</creatorcontrib><creatorcontrib>de Wiele, Tom Van</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alava, Pradeep</au><au>Tack, Filip</au><au>Laing, Gijs Du</au><au>de Wiele, Tom Van</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed. Chromatogr</addtitle><date>2012-04</date><risdate>2012</risdate><volume>26</volume><issue>4</issue><spage>524</spage><epage>533</epage><pages>524-533</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>ABSTRACT Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>21905058</pmid><doi>10.1002/bmc.1700</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-3879
ispartof Biomedical chromatography, 2012-04, Vol.26 (4), p.524-533
issn 0269-3879
1099-0801
language eng
recordid cdi_crossref_primary_10_1002_bmc_1700
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects arsenic
Arsenic - analysis
Arsenic - metabolism
Arsenicals - analysis
Arsenicals - metabolism
AsIII
AsV
Calibration
Carcinogens - analysis
Carcinogens - metabolism
Chromatography, High Pressure Liquid - methods
colon suspension
DMAIII
DMAV
gastrointestinal
Gastrointestinal Tract - microbiology
Humans
intestine
Mass Spectrometry - methods
Metagenome
Methylation
MMAIII
MMAV
nonequimolar
Sensitivity and Specificity
SHIME
speciation
title HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HPLC-ICP-MS%20method%20development%20to%20monitor%20arsenic%20speciation%20changes%20by%20human%20gut%20microbiota&rft.jtitle=Biomedical%20chromatography&rft.au=Alava,%20Pradeep&rft.date=2012-04&rft.volume=26&rft.issue=4&rft.spage=524&rft.epage=533&rft.pages=524-533&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.1700&rft_dat=%3Cwiley_cross%3EBMC1700%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21905058&rfr_iscdi=true